HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.17
Day range
$0.17 - $0.19
Year range
$0.075 - $0.40
Market cap
11.01M CAD
Avg Volume
61.90K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
FXLeaders
23 minutes ago
Last Week’s Stock Market Rally Fades: New Tensions Weigh on Dow Jones Futures
0.13%
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 256.72K | -51.40% |
Net income | -295.58K | 39.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 274.17K | 360.56% |
Total assets | 319.62K | 45.89% |
Total liabilities | 4.18M | 10.96% |
Total equity | -3.86M | — |
Shares outstanding | 57.99M | — |
Price to book | -2.36 | — |
Return on assets | -128.02% | — |
Return on capital | 44.41% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Net income | -295.58K | 39.13% |
Cash from operations | -434.36K | -1,546.37% |
Cash from investing | — | — |
Cash from financing | 75.00K | 2,757.14% |
Net change in cash | -359.36K | -1,412.59% |
Free cash flow | -341.95K | -420.51% |
About
Founded
2021
Headquarters
Website
